Page last updated: 2024-09-03

6-fluoro-3-tyrosine and carbidopa

6-fluoro-3-tyrosine has been researched along with carbidopa in 3 studies

Compound Research Comparison

Studies
(6-fluoro-3-tyrosine)
Trials
(6-fluoro-3-tyrosine)
Recent Studies (post-2010)
(6-fluoro-3-tyrosine)
Studies
(carbidopa)
Trials
(carbidopa)
Recent Studies (post-2010) (carbidopa)
19022,574465701

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chirakal, R; Firnau, G; Garnett, ES; Nahmias, C; Wahl, L1
Chen, JJ; Chirakal, R; Nahmias, C; Thompson, M; Wahl, LM1
Bankiewicz, KS; Bringas, J; Budinger, TF; Cunningham, J; Eberling, JL; Harvey-White, J; Jagust, W; Kohutnicka, M; Pivirotto, P1

Other Studies

3 other study(ies) available for 6-fluoro-3-tyrosine and carbidopa

ArticleYear
A probe for intracerebral aromatic amino-acid decarboxylase activity: distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Aromatic-L-Amino-Acid Decarboxylases; Blood-Brain Barrier; Brain; Carbidopa; Corpus Striatum; Dopamine; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Parkinson Disease; Radionuclide Imaging; Reference Values; Tyrosine

1995
The time course of metabolites in human plasma after 6-[(18)F]fluoro-l-m-tyrosine administration.
    European journal of nuclear medicine, 1999, Volume: 26, Issue:11

    Topics: Antiparkinson Agents; Brain; Carbidopa; Dopamine; Fluorine Radioisotopes; Humans; Parkinson Disease; Time Factors; Tomography, Emission-Computed; Tyrosine

1999
Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
    Experimental neurology, 2000, Volume: 164, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Carbidopa; Catheterization; Caudate Nucleus; Cell Line; Dependovirus; Dopamine; Drug Administration Routes; Drug Combinations; Fluorine Radioisotopes; Genetic Therapy; Genetic Vectors; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Neurons; Parkinson Disease, Secondary; Prodrugs; Putamen; Tomography, Emission-Computed; Tyrosine; Tyrosine 3-Monooxygenase

2000